Research Article
Prevalence and Molecular Genetics of Methicillin-Resistant Staphylococcus aureus Colonization in Nursing Homes in Saudi Arabia
Table 1
Antibiotic resistant profile of MRSA isolates from elderly residents and nurses.
| Antimicrobial agent | MIC range (μg/mL) | Resistant (n = 17) n (%) | MRSA SCCmec types (n = 14) | IVa (n = 2) n (% R) | IVc (n = 7) n (% R) | V (n = 5) n (% R) |
| Benzylpenicillin | >= 0.5 | 17 (100) | 2 (100) | 7 (100) | 5 (100) | Cloxacillin | >= 0.5 | 17 (100) | 2 (100) | 7 (100) | 5 (100) | Oxacillin | 0.25–4 | 17 (100) | 2 (100) | 7 (100) | 5 (100) | Cefaclor | 0.25–4 | 17 (100) | 2 (100) | 7 (100) | 5 (100) | Gentamicin | 0.50–16 | 8 (47.06) | 1 (50) | 4 (57.14) | 1 (20) | Levofloxacin | 0.12–8 | 3 (17.65) | 0 (0.0) | 1 (14.28) | 1 (20) | Erythromycin | 0.25–8 | 10 (58.82) | 2 (100) | 5 (71.43) | 2 (40) | Clindamycin | 0.25–8 | 9 (52.94) | 1 (50) | 5 (71.43) | 2 (40) | Teicoplanin | 0.50–32 | 1 (5.88) | 0 (0.0) | 0 (0.0) | 0 (0.0) | Vancomycin | 0.50–2 | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | Tetracycline | 1–16 | 1 (5.88) | 1 (50) | 0 (0.0) | 0 (0.0) | Tigecycline | 0.12–0.5 | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | Fosfomycin | 8–128 | 4 (23.52) | 1 (50) | 2 (28.57) | 0 (0.0) | Linezolid | 1–4 | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
|
|